Adaptive Biotechnologies Corporation Accounts Payable for the year ending December 31, 2024: USD 7.26 M

Adaptive Biotechnologies Corporation Accounts Payable is USD 7.26 M for the year ending December 31, 2024, a -5.88% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
  • Adaptive Biotechnologies Corporation Accounts Payable for the year ending December 31, 2023 was USD 7.72 M, a -4.52% change year over year.
  • Adaptive Biotechnologies Corporation Accounts Payable for the year ending December 31, 2022 was USD 8.08 M, a 144.45% change year over year.
  • Adaptive Biotechnologies Corporation Accounts Payable for the year ending December 31, 2021 was USD 3.31 M, a 2.16% change year over year.
  • Adaptive Biotechnologies Corporation Accounts Payable for the year ending December 31, 2020 was USD 3.24 M, a -27.31% change year over year.
Key Data
Date Accounts Payable Short-Term Debt Long-Term Debt Total Liabilities